Merck KGaA, Darmstadt, Germany Strengthens Oncology Portfolio
Abbisko Therapeutics has reported updated results from a Phase Ib study of Pimicotinib (ABSK021) for the treatment of advanced tenosynovial giant cell tumour (TGCT).
Abbisko presents the research results of 5 programs at the 2023 AACR Annual Meeting
A Shanghai-based biotech is handing off rights to one of its candidates to another Shanghai company.